Live Breaking News & Updates on ஹான்ஸ் பீட்டர் ஹேஸ்லர்

Stay updated with breaking news from ஹான்ஸ் பீட்டர் ஹேஸ்லர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Shield Therapeutics Announcements | Shield Therapeutics: PDMR Transaction Notification


A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
1. Obtains access to the information in a personal capacity;
2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so; ....

United Kingdom , City Of , Hans Peter Hasler , Paul Mcmanus Lianne Cawthorne , Geoff Nash Matthew , Tim Watts , London Stock Exchange , Cap Ltd , Shield Therapeutics , Non Executive Chairman , Abuse Regulation , Ordinary Shares , Stock Exchange , Joint Broker , Matthew Radley , Lianne Cawthorne , Investegate Announcements , Investegate Company Announcements , Regulatory News Service , Regulatory News Service And , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , ஹான்ஸ் பீட்டர் ஹேஸ்லர் , பால் மக்ம்யாநஸ் லியந் காவ்தோர்ன் , ஜியோஃப் நஷ் மேத்யூ , நேரம் வாட்ஸ் ,

DIRECTOR DEALINGS: Man and Rio Tinto execs sell; IHG non-exec buys


DIRECTOR DEALINGS: Man and Rio Tinto execs sell; IHG non-exec buys
Fri, 5th Mar 2021 16:07
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News:
Man Group PLC - London-based fund manager - Chief Operating Officer & General Counsel Robyn Grew sells 400,000 shares at 161.71, worth GBP646,860, on Thursday.
InterContinental Hotels Group PLC - Denham, England-based hotelier - Non-Executive Director Richard Anderson buys 7,000 American Depositary Receipts at USD71.73, worth USD502,076, on Wednesday. Each ADR represents one ordinary IHG share.
Rio Tinto PLC - London-based miner - Peter Toth, head of group Strategy & Development, sells 3,149 shares at GBP64.78, worth GBP203,991, on Wednesday. ....

City Of London , City Of , United Kingdom , United States , Richard Anderson , Ray Chamberlain , Samantha Smith , Carmen Hasler , Tazim Essani , Peter Toth , Trevor Brown , Robert Lister , Hans Peter Hasler , Kevin Magner , Diane Seymour Williams , Jeff Nodland , Tom Waite , Intercontinental Hotels Group , Strategy Development , Rio Tinto , Alliance News , Forward Nominees Ltd , Man Group , Electra Private Equity , City Of London Investment Group , Mercia Asset Management ,

Investegate |Gain Therapeutics Announcements | Gain Therapeutics: Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors


Gain Therapeutics
Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors
Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors
BETHESDA, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. (“Gain”) today announced the addition of Dov Goldstein, M.D., Gwen Melincoff, Claude Nicaise, M.D. and Hans Peter Hasler as independent members to its Board of Directors. The new board additions will provide strategic guidance as the company focuses on identifying and optimizing allosteric binding sites that have never before been targeted to unlock new treatment options for difficult-to-treat disorders characterized by protein misfolding. In conjunction with the new additions, Dr. Lorenzo Leoni and Dr. Marianne Bjordal will be stepping down from Board. ....

United Kingdom , Bruxelles Capitale , United States , City Of , Khalid Islam , Lorenzo Leoni , Minerva Neurosciences , Bristol Myers Squibb , Gwen Melincoff , Hans Peter Hasler , Marianne Bjordal , Claude Nicaise , Eric Richman , Soleno Therapeutics Inc , Vicuron Pharmaceuticals Inc , Esperion Therapeutics Inc , Department Of Medicine At Columbia , Global Development , Biogen Inc , Eastman Kodak , Collegium Pharmaceutical Inc , Silverstein Foundation For Parkinson , Health Care Administration , George Washington University , Lifesci Communications , Pfizer Inc ,

Gain Therapeutics Strengthens Leadership Team with the Appointment of Four Industry Leaders to Its Board of Directors


(2)
BETHESDA, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. ( Gain ) today announced the addition of Dov Goldstein, M.D., Gwen Melincoff, Claude Nicaise, M.D. and Hans Peter Hasler as independent members to its Board of Directors. The new board additions will provide strategic guidance as the company focuses on identifying and optimizing allosteric binding sites that have never before been targeted to unlock new treatment options for difficult-to-treat disorders characterized by protein misfolding. In conjunction with the new additions, Dr. Lorenzo Leoni and Dr. Marianne Bjordal will be stepping down from Board.
We are pleased to welcome such a distinguished group of board members at this pivotal time for Gain, said Eric Richman, Chief Executive Officer at Gain. Their decades of experience across the biopharmaceutical industry will be invaluable as we continue to advance our pipeline and determine how our proprietary Site-Directed Enzyme Enhancement Th ....

United Kingdom , Bruxelles Capitale , United States , City Of , Khalid Islam , Lorenzo Leoni , Minerva Neurosciences , Bristol Myers Squibb , Gwen Melincoff , Hans Peter Hasler , Kostenloser Wertpapierhandel , Marianne Bjordal , Claude Nicaise , Eric Richman , Soleno Therapeutics Inc , Vicuron Pharmaceuticals Inc , Esperion Therapeutics Inc , Department Of Medicine At Columbia , Global Development , Biogen Inc , Eastman Kodak , Collegium Pharmaceutical Inc , Health Care Administration , George Washington University , Lifesci Communications , Pfizer Inc ,